The surfaces of the human body host colonies of microorganisms, known as microbiomes. Along with bacteria which have a positive effect on human health, microbiomes contain potentially life-threatening pathogens. In the past, broad-spectrum antibiotics have often been used to tackle them. Nowadays it is known that this not only promotes resistance to antibiotics – in many cases it also damages the microbiome as a whole. The researchers of the Cluster of Excellence CMFI aim to develop new strategies to control microbial mechanisms and fight infections. Their common goal is to elucidate the mechanisms of interaction between beneficial and harmful bacteria and the host in order to develop novel targeted therapeutic and anti-infective treatments.
The Cluster of Excellence brings together researchers from infection biology, immunology, bioinformatics, pharmaceutical biology, antibiotics research, molecular and medical microbiology, biotechnology, environmental biology, systems biology, chemistry, as well as medical history and ethics. In addition to the University of Tübingen, the University Hospital Tübingen and the Max Planck Institute for Biology are involved in the CMFI cluster.
All further information about research, current developments and the team can be found on the CMFI homepage.